Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data

Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data Publisher Pubmed

Yoo SGK¹ ; Chung GS² ; Bahendeka SK^{3, 4} ; Sibai AM⁵ ; Damasceno A^{6, 7} ; Farzadfar F⁸ ; Rohloff P^{9, 10} ; Houehanou C¹¹ ; Norov B¹² ; Karki KB¹³ ; Azangoukhyavy M⁸ ; Marcus ME¹⁴ ; Aryal KK^{15, 16} ; Brant LCC^{17, 18} Show All Authors

Yoo SGK¹
Chung GS²
Bahendeka SK^{3, 4}
Sibai AM⁵
Damasceno A^{6, 7}
Farzadfar F⁸
Rohloff P^{9, 10}
Houehanou C¹¹
Norov B¹²
Karki KB¹³
Azangoukhyavy M⁸
Marcus ME¹⁴
Aryal KK^{15, 16}
Brant LCC^{17, 18}
Theilmann M^{19, 20}
Cifkova R^{21, 22}
Lunet N^{23, 24, 25}
Gurung MS²⁶
Mwangi JK^{27, 28}
Martins J²⁹
Haghshenas R⁸
Sturua L^{30, 31}
Vollmer S³²
Barnighausen T^{19, 33, 34}
Atun R^{35, 36}
Sussman JB^{2, 37}
Singh K^{19, 38}
Moghaddam SS^{39, 40}
Guwatudde D⁴¹
Geldsetzer P^{42, 43}
Mannegoehler J^{14, 44}
Huffman MD^{45, 46, 47}
Davies JI^{48, 49}
Flood D^{2, 50, 51}

Source: Global heart Published:2024

Abstract

[No abstract available]

Style	Citing Format
MLA	Yoo SGK, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart, vol. 19, no. 1, 2024, pp. 44-.
APA	Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangoukhyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cifkova R, Lunet N, Gurung MS, Mwangi JK, ... Flood D (2024). Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart, 19(1), 44-.
Chicago	Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart 19, no. 1 (2024): 44-.
Harvard	Yoo SGK et al. (2024) 'Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data', Global heart, 19(1), pp. 44-.
Vancouver	Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, et al.. Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart. 2024;19(1):44-.
BibTex	@article{ author = {Yoo SGK and Chung GS and Bahendeka SK and Sibai AM and Damasceno A and Farzadfar F and Rohloff P and Houehanou C and Norov B and Karki KB and Azangoukhyavy M and Marcus ME and Aryal KK and Brant LCC and Theilmann M and Cifkova R and Lunet N and Gurung MS and Mwangi JK and Martins J and Haghshenas R and Sturua L and Vollmer S and Barnighausen T and Atun R and Sussman JB and Singh K and Moghaddam SS and Guwatudde D and Geldsetzer P and Mannegoehler J and Huffman MD and Davies JI and Flood D}, title = {Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data}, journal = {Global heart}, volume = {19}, number = {1}, pages = {44-}, year = {2024} }
RIS	TY - JOUR AU - Yoo SGK AU - Chung GS AU - Bahendeka SK AU - Sibai AM AU - Damasceno A AU - Farzadfar F AU - Rohloff P AU - Houehanou C AU - Norov B AU - Karki KB AU - Azangoukhyavy M AU - Marcus ME AU - Aryal KK AU - Brant LCC AU - Theilmann M AU - Cifkova R AU - Lunet N AU - Gurung MS AU - Mwangi JK AU - Martins J AU - Haghshenas R AU - Sturua L AU - Vollmer S AU - Barnighausen T AU - Atun R AU - Sussman JB AU - Singh K AU - Moghaddam SS AU - Guwatudde D AU - Geldsetzer P AU - Mannegoehler J AU - Huffman MD AU - Davies JI AU - Flood D TI - Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data JO - Global heart VL - 19 IS - 1 SP - 44 EP - PY - 2024 ER -

Style

Citing Format

MLA

Yoo SGK, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart, vol. 19, no. 1, 2024, pp. 44-.

APA

Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangoukhyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cifkova R, Lunet N, Gurung MS, Mwangi JK, ... Flood D (2024). Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart, 19(1), 44-.

Chicago

Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart 19, no. 1 (2024): 44-.

Harvard

Yoo SGK et al. (2024) 'Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data', Global heart, 19(1), pp. 44-.

Vancouver

Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, et al.. Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart. 2024;19(1):44-.

BibTex

@article{ author = {Yoo SGK and Chung GS and Bahendeka SK and Sibai AM and Damasceno A and Farzadfar F and Rohloff P and Houehanou C and Norov B and Karki KB and Azangoukhyavy M and Marcus ME and Aryal KK and Brant LCC and Theilmann M and Cifkova R and Lunet N and Gurung MS and Mwangi JK and Martins J and Haghshenas R and Sturua L and Vollmer S and Barnighausen T and Atun R and Sussman JB and Singh K and Moghaddam SS and Guwatudde D and Geldsetzer P and Mannegoehler J and Huffman MD and Davies JI and Flood D}, title = {Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data}, journal = {Global heart}, volume = {19}, number = {1}, pages = {44-}, year = {2024} }

RIS

TY - JOUR
AU - Yoo SGK
AU - Chung GS
AU - Bahendeka SK
AU - Sibai AM
AU - Damasceno A
AU - Farzadfar F
AU - Rohloff P
AU - Houehanou C
AU - Norov B
AU - Karki KB
AU - Azangoukhyavy M
AU - Marcus ME
AU - Aryal KK
AU - Brant LCC
AU - Theilmann M
AU - Cifkova R
AU - Lunet N
AU - Gurung MS
AU - Mwangi JK
AU - Martins J
AU - Haghshenas R
AU - Sturua L
AU - Vollmer S
AU - Barnighausen T
AU - Atun R
AU - Sussman JB
AU - Singh K
AU - Moghaddam SS
AU - Guwatudde D
AU - Geldsetzer P
AU - Mannegoehler J
AU - Huffman MD
AU - Davies JI
AU - Flood D
TI - Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
JO - Global heart
VL - 19
IS - 1
SP - 44
EP -
PY - 2024
ER -

Science Communicator Platform

Authors

Abstract